As one of the three national academies forming the Council of Canadian Academies, the CAHS draws on the expertise of the country's top health sciences researchers to assess Canada's most pressing and complex health challenges and provide strategic, actionable recommendations. This year, a total of 49 researchers have been elected to the Academy, which is considered one of the highest honours for individuals in the Canadian health sciences community.
Dr. Goodwin is a Senior Investigator at the Lunenfeld-Tanenbaum Research Institute (LTRI), part of Sinai Health, and former inaugural Director of Sinai Health’s Marvelle Koffler Breast Cancer Centre. She is internationally renowned for her pioneering research on the role of obesity and other host factors in breast cancer. Her research has directly informed clinical practice through the initiation of patient-centered programs addressing obesity and lifestyle, initially at Mount Sinai Hospital, and subsequently at cancer centers nationally and internationally. Her current research is focused on identifying biomarkers that can predict the risk of breast cancer recurrence in survivors.
Dr. Haider is a Senior Clinician Scientist and Director of the Research, Magnetic Resonance Imaging (MRI, and Head of the Radiomics and Machine Learning Lab at LTRI. He has gained global recognition as a pioneer in the development and implementation of MRI approaches for diagnosis, prognosis and treatment of prostate cancer. He was instrumental in establishing this technology as part of the standard of care for prostate cancer patients in Canada and is currently leading the development of AI and machine learning tools that detect tumors in medical imaging scans.
Dr. Anne-Claude Gingras, Director of LTRI and Vice President of Research at Sinai Health, said, “I am thrilled to congratulate Dr. Goodwin and Dr. Haider on their well-deserved recognition as Fellows of the Canadian Academy of Health Sciences. Their induction is not only a testament to their past achievements but also a gateway to their future contributions. I am confident that their innovative work will greatly enrich the Academy's endeavors and drive forward the advancement of health sciences in Canada and beyond.”
